The Patent Finder
US

Novel Compound Useful for the Treatment of Degenerative and Inflammatory Diseases

US 8,802,682 In force
OverviewFamilyAssignmentsSources & methods

Term ends Jul 27, 2032 · High confidence

Filed Apr 27, 2012 as application 13/459,055 · Granted Aug 12, 2014
Base term plus 91 days of patent term adjustment (USPTO delay)
Today
20 years from filing
2012 2032
Clock starts
Apr 27, 2012
Term ends
Jul 27, 2032
Granted
Aug 12, 2014
base term patent term adjustment fee events Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
91
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
4
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term runs 91 days past its 20-year base term on prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Apr 27, 2012, when this application, 13/459,055, was filedApr 27, 2032High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustment+91 days, USPTO patent term adjustment recordJul 27, 2032High confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events3 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderJul 27, 2032High confidence

This family

US 8,802,682this patent
Jul 2032
Jul 2032
US 9,241,931In force
Apr 2032
Apr 2032
US 9,987,272In force
Apr 2032
Apr 2032
Application 15/694,454Abandoned
not computed
not computed
Every application listed has its file history here. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
May 31, 2012
Reel 28293, frame 508
Menet, Christel Jeanne Marie; Hodges, Alastair James; Vater, Huw David; Biofocus Dpi Ltd.Galapagos N.V.Assignment of Assignor's Interest
Aug 23, 2019
Reel 50149, frame 161
Galapagos N.V.Gilead Sciences, Inc.Security Interest
Jun 4, 2026
Reel 74845, frame 68
GalapagosLakefront BiotherapeuticsChange of Name

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited